This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,465.36 contract is for the supply of 4,566,433,889 units of Cyclophosphamide 2 gm vials, a critical cancer treatment medication. The contract has an ultimate completion date of November 15, 2024 and was awarded on November 14, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is part of that larger IDC mechanism, enabling efficient government procurement of essential medications to serve the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Generated 2/27/25, 10:21 AM